NCT07396454 2026-02-09Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With AnlotinibThe First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Recruiting39 enrolled